Company Mission

BIOTON aims to reinforce its position of a biotechnological company with a global reach.
The Company is able to pursue its strategic objectives of protecting Patients’ health and improving the quality of their lives by participating in research and development projects, promoting the expansion of its product portfolio and making well-informed business decisions.
BIOTON fulfils its stated mission by implementing strategies and development plans aimed at:

• reinforcing BIOTON's status on the Polish insulin market
• promoting BIOTON's insulin world-wide by maximising its share of the existing markets and entering new ones
• developing innovative, clinically important medicinal products, including biotechnological drugs developed by members of the BIOTON Group
• expanding BIOTON’s generic drug portfolio.

drukuj

About us

• Company Mission
• Management of the Company
• Key events in BIOTON's history
• Research and development
• Quality Management
• Sales targets and global expansion
• Members of the BIOTON Group
• In/out licensing
• Contact for media
• Cooperation with the European Union
• Contact

Bioton WorldWide

Bioton group

• Scigenltd.com
• Biopartners
• Bioton IBA Wostok
• Fisiopharma S.r.l.
• Pharmatex Italia
• Scigen

GPW

Contact for media:

Jacek Zawadzki
jzawadzki@egzogroup.pl
Mobile: +48 694 400 222

Contact for investors:

Jacek Zawadzki
jzawadzki@egzogroup.pl 
Mobile: +48 694 400 222